November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
May 14, 2026 - 09:51
A&B Business Solutions: Strategic Partnership Formed With Technology Company JD Young TechnologiesA&B Business Solutions has announced a new strategic partnership with JD Young Technologies, uniting two family-owned companies that share a focus on long-term growth and customer service. The...
May 13, 2026 - 21:17
Council approves funding for surveillance technologyAsheville City Council voted to approve funding for new surveillance technology on May 12, drawing sharp criticism from residents who packed the council chamber. The meeting, which took place at...
May 13, 2026 - 01:16
ASU a key partner in US-Taiwan technology relationshipIn 2016, the Taiwan Semiconductor Manufacturing Co., known as TSMC, was searching for a U.S. city to host its massive $165 billion semiconductor manufacturing complex. Company officials visited...
May 12, 2026 - 00:41
Texas’ new AI division is helping agencies test new technologyAUSTIN -- Texas has created a new artificial intelligence division within its state government to assist agencies in evaluating and adopting AI tools. The unit, announced by Texas Chief Information...